Ipsen S.A.

Pharmaceuticals

Company Summary

Ipsen S.A. is a biopharmaceutical firm with operations all over the world. Oncology, neuroscience, gastrointestinal, cognitive disorders, and uncommon diseases are among areas where the company delivers medications. Ipsen S.A. is based in Boulogne-Billancourt, France, and was founded in 1929.

ESG Rating Overview

Sustainalytics

Overall ESG Rating :

27
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
0100E1.1S16.3G10

Refinitiv

Overall ESG Rating :

63
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
0100E93S78G19

Overall ESG Rating :

A
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader

Ipsen is average among 86 companies in the pharmaceuticals industry.

Temperature Rise :

1.66℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned